OLMA - Olema Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$41.88
DETAILS
HIGH:
$48.00
LOW:
$35.00
MEDIAN:
$41.50
CONSENSUS:
$41.88
UPSIDE:
206.14%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 986,827 | $14.7M | 0.4% | +986,827 | NEW |
| Cooperman | 39,230 | $584,920 | 0.0% | +29,276 | INCREASED |
| Wood | 38,600 | $575,526 | 0.0% | +24,500 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-28 | Raman Prakash | director | A-Award | 24,150 | $14.59 | $352K |
| 2026-04-28 | Raman Prakash | ? | -- | -- | -- | |
| 2026-04-28 | Raman Prakash | director | A-Award | 2,911 | $14.59 | $42K |
| 2026-03-04 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 25,000 | $4.37 | $109K |
| 2026-03-03 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 15,000 | $4.37 | $66K |
| 2026-03-04 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | SELL | 24,767 | $24.25 | $601K |
| 2026-03-04 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | SELL | 233 | $24.69 | $6K |
| 2026-03-03 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | SELL | 15,000 | $23.01 | $345K |
| 2026-02-02 | Austin Sasha Lu | officer: VP of Finance and Controller | A-Award | 11,700 | -- | -- |
| 2026-01-30 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | -- | -- | -- |
| 2026-02-01 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | 13,000 | $2.44 | $32K |
| 2026-02-02 | Austin Sasha Lu | officer: VP of Finance and Controller | A-Award | 29,250 | $25.65 | $750K |
| 2026-01-30 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | 45,000 | $4.37 | $197K |
| 2026-01-30 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | 6,500 | $4.87 | $32K |
| 2026-01-30 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | 17,500 | $3.49 | $61K |
| 2026-01-30 | Austin Sasha Lu | officer: VP of Finance and Controller | ? | 51,000 | $15.25 | $778K |
| 2026-02-02 | Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | A-Award | 106,250 | $25.65 | $2.7M |
| 2026-02-02 | Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | A-Award | 250,000 | $25.65 | $6.4M |
| 2026-02-02 | Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | A-Award | 106,250 | $25.65 | $2.7M |
| 2026-02-02 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | A-Award | 220,000 | $25.65 | $5.6M |
| 2026-02-02 | Bohen Sean | director, officer: PRESIDENT AND CEO | A-Award | 275,000 | $25.65 | $7.1M |
| 2026-02-02 | Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | A-Award | 250,000 | $25.65 | $6.4M |
| 2026-02-02 | Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | A-Award | 56,250 | $25.65 | $1.4M |
| 2026-02-02 | Bohen Sean | director, officer: PRESIDENT AND CEO | A-Award | 850,000 | $25.65 | $21.8M |
| 2026-01-20 | Harmon Cyrus | director | SELL | 10,000 | $26.88 | $269K |